Callan Capital’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$6.13M Sell
66,308
-9,527
-13% -$928K 0.45% 40
2024
Q4
$7.35M Sell
75,835
-32
-0% -$3.14K 0.54% 35
2024
Q3
$7.22M Sell
75,867
-6,883
-8% -$632K 0.5% 38
2024
Q2
$7.46M Sell
82,750
-7,294
-8% -$644K 0.61% 28
2024
Q1
$8.06M Sell
90,044
-8,521
-9% -$720K 0.71% 27
2023
Q4
$8.04M Sell
98,565
-20,846
-17% -$1.58M 0.76% 26
2023
Q3
$8.75M Sell
119,411
-1,604
-1% -$122K 0.94% 25
2023
Q2
$9.1M Sell
121,015
-50,897
-30% -$3.64M 1.01% 23
2023
Q1
$12.2M Buy
171,912
+9,351
+6% +$662K 1.41% 20
2022
Q4
$11.1M Buy
162,561
+70,943
+77% +$4.85M 1.37% 19
2022
Q3
$5.71M Buy
+91,618
New +$6.29M 0.93% 24

Other funds holding AVUS

Callan Capital's AVUS Position: Q1 2025 in Review

Callan Capital reduced its Avantis US Equity ETF (AVUS) stake by 13% in Q1 2025, selling an estimated $928K and leaving 66,308 shares worth $6.13M. The position accounts for 0.45% of the portfolio, ranked #40.

Callan Capital first reported a position in AVUS in Q3 2022 and has held it in 11 quarters since. The position peaked at $12.2M in Q1 2023. 446 funds tracked by Wall St. Rank hold AVUS as of Q1 2025.

  • Callan Capital held 66,308 shares of Avantis US Equity ETF worth $6.13M as of Q1 2025.
  • Callan Capital sold 9,527 Avantis US Equity ETF shares in Q1 2025, an estimated $928K.
  • Avantis US Equity ETF made up 0.45% of Callan Capital's portfolio in Q1 2025, its #40 holding.
  • Callan Capital first reported a position in Avantis US Equity ETF in Q3 2022 and has held it in 11 quarters since.
  • Callan Capital's Avantis US Equity ETF position peaked at $12.2M in Q1 2023.
  • 446 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.